Completion of Tranche 2 of Investment
Brisbane, April 13, 2022 AEST (ABN Newswire) - Fiji Kava Limited (
ASX:FIJ) is a health and wellness company with operations in Australia, Fiji, and the USA. The company which produces natural products to reduce anxiety, promote relaxation, improve sleep, and support sports recovery advises that as per the previously announced partnership with IMCD-Network Nutrition (dated 26th October 2021), tranche 2 of investment by principal Ryan Gorman has been completed - being 1,000,000 shares (FIJ) priced at 12c and 1,000,000 options (FIJO) priced at 0.5c.
Mr Gorman also joined the Board of Directors of FijiKava Inc. USA, a wholly owned subsidiary of Fiji Kava Ltd.
Continued sales growth in the USA ingredient market has been achieved through the partnership between Fiji Kava and Network Nutrition each quarter since the agreement was put in place.
About Fiji Kava Limited
Fiji Kava Limited (ASX: FIJ) is an Australian-Fijian medicinal kava health & wellness company, producing natural 'noble kava' products for the complementary and alternative medicine market, estimated to exceed USD $210 billion by 2026 globally. As the first foreign company with approval from the Fijian Government to operate in the kava industry, FijiKava has established a global leading sustainable and 100% traceable, certified organic supply chain of 'noble kava' including a nucleus farm in Levuka, on the island of Ovalau, Fiji.
FijiKava is focused on expanding the availability of noble kava products throughout western markets to provide a natural alternative to prescription medicines to promote sleep, soothe and calm the nerves, support muscle relaxation and relax the mind.
| ||
|
